Table 1 Compilation of clinical data of the breast cancer patients used in the study.
From: Gene expression variation to predict 10-year survival in lymph-node-negative breast cancer
10-year survivors | deceased | Total | |
|---|---|---|---|
Mean age | 48 | 53 | 50 |
Surgery | |||
breast preserving | 11 | 11 | 22 |
mastectomy | 12 | 12 | 24 |
total | 23 | 23 | 46 |
Histology | |||
ductal | 19 | 14 | 33 |
lobular | 1 | 2 | 3 |
mucinous | 2 | 0 | 2 |
medullary | 0 | 1 | 1 |
tubular | 0 | 1 | 1 |
comedocarcinoma | 0 | 1 | 1 |
adenocarcinoma | 0 | 1 | 1 |
not available | 1 | 3 | 4 |
total | 23 | 23 | 46 |
Receptor Status | |||
estrogen positive | 12 | 11 | 23 |
progesterone positive | 11 | 5 | 16 |
unavailable | 1 | 0 | 1 |
Ploidi | |||
diploid | 7 | 3 | 10 |
aneuploid | 13 | 13 | 26 |
polyploid | 2 | 2 | 4 |
not available | 1 | 5 | 6 |
total | 23 | 23 | 46 |
S-phase | |||
< 12% | 14 | 7 | 21 |
>= 12% | 3 | 8 | 11 |
not available | 6 | 8 | 14 |
total | 23 | 23 | 46 |